Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Proteolytic starter cultures with intrinsic immunomodulatory activities are desirably features for the development of functional foods, which would significantly reduce the cost of their production (one-strain starter) having an additional beneficial effect on the host. In this work, Lactobacillus delbrueckii strains were selected according to their ability to efficiently hydrolyse β-casein and to modulate the immune system. Among 36 strains evaluated, the highest proteolytic activities were found for L. delbrueckii subsp. lactis CRL581 and L. delbrueckii subsp. bulgaricus CRL656. The immunomodulatory effect of both strains and their β-casein hydrolysates (CRL581 and CRL656 hydrolysates, respectively) were studied in a murine model. Balb/c mice were fed lactobacilli or their hydrolysates for three days. One day after the last lactobacilli or hydrolysate treatments, mice were challenged with the Toll-like receptor 3 (TLR3) agonist poly(I:C) by intraperitoneal injection. Before and after poly(I:C) challenge the phagocytic and microbicidal activity of peritoneal macrophages, intestinal immunoglobulin A (IgA), cytokine profile, and histological analysis of the intestine were analysed. L. delbrueckii subsp. lactis CRL581 significantly increased the activation of peritoneal macrophages as well as the levels of intestinal IgA, interleukin (IL)-10 and interferon (IFN)-γ when compared to untreated controls. In addition, the CRL581 strain was able to significantly reduce the intestinal inflammatory damage triggered by TLR3 activation. L. delbrueckii CRL581 increased the levels of IL-10, IFN-γ and IFN-β, and reduced tumour necrosis factor alpha and IL-6 concentrations in the intestine of poly(I:C)-challenged mice. No immunomodulatory effects were observed for the CRL656 strain or for the CRL581 or CRL656 hydrolysates. The results of this work show that the technologically relevant and high proteolytic strain L. delbrueckii CRL581 is able to beneficially modulate the intestinal innate antiviral immune response. Although further studies with the CRL581 strain are required to corroborate and deepen its immunological effects, this bacterium is an interesting alternative for the development of new functional foods with antiviral capabilities.
Kauf
Sofortzugang erwerben (PDF-Download und unbegrenzter Online-Zugang):
Institutszugang
Melden Sie sich mit Open Athens, Shibboleth oder Ihren institutionellen Anmeldedaten an.
Persönliche Anmeldung
Melden Sie sich mit Ihrem brill.com-Konto an
Albarracin, L., Kobayashi, H., Iida, H., Sato, N., Nochi, T., Aso, H., Salva, S., Alvarez, S., Kitazawa, H. and Villena, J., 2017. Transcriptomic analysis of the innate antiviral immune response in porcine intestinal epithelial cells: influence of immunobiotic lactobacilli. Frontiers in Immunology 8: 57. https://doi.org/10.3389/fimmu.2017.00057
Araya, R.E., Jury, J., Bondar, C., Verdu, E.F. and Chirdo, F.G., 2014. Intraluminal administration of poly I:C causes an enteropathy that is exacerbated by administration of oral dietary antigen. PLoS ONE 9: e99236. https://doi.org/10.1371/journal.pone.0099236
Bardach, A., Ciapponi, A., Garcia-Marti, S., Glujovsky, D., Mazzoni, A., Fayad, A., Colindres, R. and Gentile, A., 2011. Epidemiology of acute otitis media in children of Latin America and the Caribbean: a systematic review and meta-analysis. International Journal of Pediatric Otorhinolaryngology 75: 1062-1070. https://doi.org/10.1016/j.ijporl.2011.05.014
Bass, D.M., 1997. Interferon gamma and interleukin 1, but not interferon alfa, inhibit rotavirus entry into human intestinal cell lines. Gastroenterology 113: 81-89. https://doi.org/10.1016/S0016-5085(97)70083-0
Blutt, S.E. and Conner, M.E., 2013 The gastrointestinal frontier: IgA and viruses. Frontiers in Immunology 4: 402. https://doi.org/10.3389/fimmu.2013.00402
Bortz, G. and Thomas, H., 2017. Biotechnologies for inclusive development: scaling up, knowledge intensity and empowerment (the case of the probiotic yoghurt ‘Yogurito’ in Argentina). Innovation and Development 7: 37-61. https://doi.org/10.1080/2157930X.2017.1281206
Broggi, A., Tan, Y., Granucci, F. and Zanoni, I., 2017. IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function. Nature Immunology 18: 1084-1093. https://doi.org/10.1038/ni.3821
Brown, L., Vera Pingitore, E., Mozzi, F., Saavedra, L., Villegas, J.M. and Hebert, E.M., 2017a. Lactic acid bacteria as cell factories for the generation of bioactive peptides. Protein and Peptide Letters 24: 146-155. https://doi.org/10.2174/0929866524666161123111333
Brown, L., Villegas, J.M., Elean, M., Fadda, S., Mozzi, F., Saavedra, L. and Hebert, E.M., 2017b. YebC, a putative transcriptional factor involved in the regulation of the proteolytic system of Lactobacillus. Scientific Reports 7: 8579. https://doi.org/10.1038/s41598-017-09124-1
Chiba, E., Tomosada, Y., Vizoso-Pinto, M.G., Salva, S., Takahashi, T., Tsukida, K., Kitazawa, H., Alvarez, S. and Villena, J., 2013. Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection. International Immunopharmacology 17: 373-382. https://doi.org/10.1016/j.intimp.2013.06.024
Clancy, R., 2003. Immunobiotics and the probiotic evolution. FEMS Immunology and Medical Microbiology 38: 9-12.
'Immunobiotics and the probiotic evolution ' () 38 FEMS Immunology and Medical Microbiology : 9 -12.
Edmond, K., Scott, S., Korczak, V., Ward, C., Sanderson, C., Theodoratou, E., Clark, A., Griffiths, U., Rudan, I. and Campbell, H., 2012. Long term sequelae from childhood pneumonia; systematic review and meta-analysis. PLoS ONE 7: e31239. https://doi.org/10.1371/journal.pone.0031239
Espeche Turbay, M.B., De Moreno de LeBlanc, A., Perdigon, G., Savoy de Giori, G. and Hebert, E.M., 2012. β-casein hydrolysate generated by the cell envelope-associated proteinase of Lactobacillus delbrueckii ssp. lactis CRL 581 protects against trinitrobenzene sulfonic acid-induced colitis in mice. Journal of Dairy Science 95: 1108-1118. https://doi.org/10.3168/jds.2011-4735
Espeche Turbay, M.B., Savoy de Giori, G. and Hebert, E.M., 2009. Release of the cell-envelope-associated proteinase of Lactobacillus delbrueckii subspecies lactis CRL 581 is dependent upon pH and temperature. Journal of Agricultural and Food Chemistry 57: 8607-8611. https://doi.org/10.1021/jf901531q
Forbes, S.J., Bumpus, T., McCarthy, E.A., Corthesy, B. and Mantis, N.J., 2011. Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA. MBio 2: e00042-11. https://doi.org/10.1128/mBio.00042-11.4
Forbes, S.J., Eschmann, M. and Mantis, N.J., 2008. Inhibition of Salmonella enterica serovar Typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin A antibody. Infection and Immuniny 76: 4137-4144. https://doi.org/10.1128/IAI.00416-08
Galdeano, C., De Moreno de LeBlanc, A., Vinderola, G., Bonet, M. and Perdigón, G., 2007. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clinical and Vaccine Immunology 14: 485-492. https://doi.org/10.1128/CVI.00406-06
Gandhi, G.R., Santos, V.S., Denadai, M., Da Silva Calisto, V.K., De Souza Siqueira Quintans, J., De Oliveira, E., Silva, A.M., De Souza Araújo, A.A., Narain, N., Cuevas, L.E., Júnior, L.J.Q. and Gurgel, R.Q., 2017. Cytokines in the management of rotavirus infection: a systematic review of in vivo studies. Cytokine 96: 152-160. https://doi.org/10.1016/j.cyto.2017.04.013
Hakim, M.S., Ding, S., Chen, S., Yin, Y., Su, J., Van der Woude, C.J., Fuhler, G.M., Peppelenbosch, M.P., Pan, Q. and Wang, W., 2018. TNF-α exerts potent anti-rotavirus effects via the activation of classical NF-κB pathway. Virus Research 253: 28-37. https://doi.org/10.1016/j.virusres.2018.05.022
Hebert, E., Mamone, G., Picariello, G., Raya, R., Savoy, G., Ferranti, P. and Addeo, F., 2008. Characterization of the pattern of αs1- and β-casein breakdown and release of a bioactive peptide by a cell envelope proteinase from Lactobacillus delbrueckii subsp. lactis CRL 581. Applied and Environmental Microbiology 74: 3682-3689. https://doi.org/10.1128/AEM.00247-08
Hebert, E., Raya, R. and Giori, G., 2004. Nutritional requirements of Lactobacillus delbrueckii subsp. lactis in a chemically defined medium. Current Microbiology 49: 341. https://doi.org/10.1007/s00284-004-4357-9
Hiramatsu, Y., Hosono, A., Konno, T., Nakanishi, Y., Muto, M., Suyama, A., Hachimura, S., Sato, R., Takahashi, K. and Kaminogawa, S., 2011. Orally administered Bifidobacterium triggers immune responses following capture by CD11c (+) cells in Peyer’s patches and cecal patches. Cytotechnology 63: 307. https://doi.org/10.1007/s10616-011-9349-6
Hoffmann, H.H., Schneider, W.M. and Rice, C.M., 2015. Interferons and viruses: an evolutionary arms race of molecular interactions. Trends in Immunology 36: 124-138. https://doi.org/10.1016/j.it.2015.01.004
Ivec, M., Botić, T., Koren, S., Jakobsen, M., Weingartl, H. and Cencic, A., 2007. Interactions of macrophages with probiotic bacteria lead to increased antiviral response against vesicular stomatitis virus. Antiviral Research 75: 266-274. https://doi.org/10.1016/j.antiviral.2007.03.013
Kanmani, P., Albarracin, L., Kobayashi, H., Hebert, E., Saavedra, L., Komatsu, R., Gatica, B., Miyazaki, A., Ikeda-Ohtsubo, W., Suda, Y., Aso, H., Egusa, S., Mishima, T., Salas-Burgos, A., Takahashi, H., Villena, J. and Kitazawa, H., 2018b. Genomic characterization of Lactobacillus delbrueckii TUA4408L and evaluation of the antiviral activities of its extracellular polysaccharides in porcine intestinal epithelial cells. Frontiers in Immunology 9: 2178. https://doi.org/10.3389/fimmu.2018.02178
Kanmanni, P., Albarracin, L., Kobayashi, H., Hebert, E., Saavedra, L., Komatsu, R., Gatica, B., Miyazaki, A., Ikeda-Ohtsubo, W., Suda, Y., Aso, H., Egusa, S., Mishima, T., Salas-Burgos, A., Takahashi, H., Villena, J. and Kitazawa, H., 2018a. Exopolysaccharides from Lactobacillus delbrueckii OLL1073R-1 modulate innate antiviral immune response in porcine intestinal epithelial cells. Molecular Immunology 93: 253-265. https://doi.org/10.1016/j.molimm.2017.07.009
Laemmli, U., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685. https://doi.org/10.1038/227680a0
Leblanc, J., Fliss, I. and Matar, C., 2004. Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus fermented milk. Clinical and Diagnostic Laboratory Immunology 11: 1171-1181. https://doi.org/10.1128/CDLI.11.6.1171-1181.2004
Lin, C., Chen, S., Liu, S. and Chen, K., 2014. Disease caused by rotavirus infection. The Open Virology Journal 8: 14-19. https://doi.org/10.2174/1874357901408010014
Lycke, N., Erlandsson, L., Ekman, L., Schon, K. and Leanderson, T., 1999. Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection. Journal of Immunology 163: 913-919.
'Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection ' () 163 Journal of Immunology : 913 -919.
Makino, S., Ikegami, S., Kano, H., Sashihara, T., Sugano, H., Horiuchi, H., Saito, T. and Oda, M., 2006. Immunomodulatory effects of polysaccharides produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Journal of Dairy Science 89: 2873-2881. https://doi.org/10.3168/jds.S0022-0302(06)72560-7
Makino, S., Sato, A., Goto, A., Nakamura, M., Ogawa, M., Chiba, Y., Hemmi, J., Kano, H., Takeda, K., Okumura, K. and Asami, Y., 2016. Enhanced natural killer cell activation by exopolysaccharides derived from yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Journal of Dairy Science 99: 915-923. https://doi.org/10.3168/jds.2015-10376
Marranzino, G., Villena, J., Salva, S. and Alvarez, S., 2012. Stimulation of macrophages by immunobiotic Lactobacillus strains: influence beyond the intestinal tract. Microbiology and Immunology 56: 771- 781. https://doi.org/10.1111/j.1348-0421.2012.00495.x
McQuade, E.T.R. and Platts-Mills, J.A., 2019. Monitoring the impact of rotavirus vaccines on a global scale. The Lancet Global Health 7: e817-e818. https://doi.org/10.1016/S2214-109X(19)30232-3
Miettinen, M., Pietilä, T.E., Kekkonen, R.A., Kankainen, M., Latvala, S., Pirhonen, J., Österlund, P., Korpela, R. and Julkunen, I., 2012. Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages. Gut Microbes 3: 510-522. https://doi.org/10.4161/gmic.21736
Nagai, T., Makino, S., Ikegami, S., Itoh, H. and Yamada, H., 2011. Effects of oral administration of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 and its exopolysaccharides against influenza virus infection in mice. International Immunopharmacology 11: 2246-2250. https://doi.org/10.1016/j.intimp.2011.09.012
Negishi, H., Osawa, T., Ogami, K., Ouyang, X., Sakaguchi, S., Koshiba, R., Yanai, H., Seko, Y., Shitara, H., Bishop, K., Yonekawa, H., Tamura, T., Kaisho, T., Taya, C., Taniguchi, T. and Honda, K., 2008. A critical link between toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proceedings of the National Academy of Sciences of the USA 105: 20446-20451. https://doi.org/10.1073/pnas.0810372105
Pabst, O., 2012. New concepts in the generation and functions of IgA. Nature Reviews Immunology 12: 821-832. https://doi.org/10.1038/nri3322
Pihlanto, A., 2016. Milk protein products: bioactive peptides. In: Fuquay, J.W., Fox, P.F. and McSweeney, P.L.H. (eds.) Encyclopedia of dairy sciences. Academic Press, San Diego, CA, USA, pp. 879-886. https://doi.org/10.1016/b978-0-08-100596-5.00932-x
Ruiz Rodríguez, L., Mohamed, F., Bleckwedel, J., Medina, R., De Vuyst, L., Hebert, E. and Mozzi, F., 2019. Diversity and functional properties of lactic acid bacteria isolated from wild fruits and flowers present in Northern Argentina. Frontiers in Microbiology 10: 1091. https://doi.org/10.3389/fmicb.2019.01091
Saavedra, L., Hebert, E., Minahk, C. and Ferranti, P., 2013. An overview of ‘omic’ analytical methods applied in bioactive peptide studies. Food Research International 54: 925-934. https://doi.org/10.1016/j.foodres.2013.02.034
Salva, S., Villena, J. and Alvarez, S., 2010. Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: impact on intestinal and respiratory infections. International Journal of Food Microbiology 141: 82-89. https://doi.org/10.1016/j.ijfoodmicro.2010.03.013
Savijoki, K., Ingmer, H. and Varmanen, P., 2006. Proteolytic systems of lactic acid bacteria. Applied Microbiology Biotechnology 71: 394-406. https://doi.org/10.1007/s00253-006-0427-1
Sen, A., Rothenberg, M.E., Mukherjee, G., Feng, N., Kalisky, T., Nair, N., Johnstone, I.M., Clarke, M.F. and Greenberg, H.B., 2012. Innate immune response to homologous rotavirus infection in the small intestinal villous epithelium at single-cell resolution. Proceedings of the National Academy of Sciences of the USA 109: 20667-20672. https://doi.org/10.1073/pnas.1212188109
Tada, A., Zelaya, H., Clua, P., Salva, S., Alvarez, S., Kitazawa, H. and Villena, J., 2016. Immunobiotic Lactobacillus strains reduce small intestinal injury induced by intraepithelial lymphocytes after toll-like receptor 3 activation. Inflammation Research 65: 771-783. https://doi/10.1007/s00011-016-0957-7
Tate, J.E., Burton, A.B., Boschi-Pinto, C., Parashar, U.D., Agocs, M., Serhan, F., De Oliveira, L., Mwenda, J.M., Mihigo, R., Ranjan, W.P., Abeysinghe, N., Fox, K. and Paladin, F., 2016. Global, regional, and national estimates of rotavirus mortality in children, 5 years of age, 2000-2013. Clinical Infectious Diseases 62: S96-105. https://doi.org/10.1093/cid/civ1013
Villena, J. and Kitazawa, H., 2014. Modulation of intestinal TLR4- inflammatory signalling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937. Frontiers in Immunology – Frontiers in Immunological Tolerance 4: 1-12. https://doi.org/10.3389/fimmu.2013.00512
Villena, J., Chiba, E., Vizoso-Pinto, M.G., Tomosada, Y., Takahashi, T., Ishizuka, T., Aso, H., Salva, S., Alvarez, S. and Kitazawa, H., 2014. Immunobiotic Lactobacillus rhamnosus strains differentially modulate antiviral immune response in porcine intestinal epithelial and antigen presenting cells. BMC Microbiology 14: 126. https://doi.org/10.1186/1471-2180-14-126
Villena, J., Medina, M., Raya, R. and Alvarez, S., 2008. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection. Canadian Journal of Microbiology 54: 845-853.
'Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection ' () 54 Canadian Journal of Microbiology : 845 -853.
Villena, J., Oliveira, M.L., Ferreira, P., Salva, S. and Alvarez, S., 2011. Lactic acid bacteria in the prevention of pneumococcal respiratory infection: future opportunities and challenges. International Immunopharmacology 11: 1633-1645. https://doi.org/10.1016/j.intimp.2011.06.004
Villena, J., Salva, S., Nuñez, M., Corzo, J., Tolaba, R., Faedda, J., Font, G. and Alvarez, S., 2012. Probiotics for everyone! The novel immunobiotic Lactobacillus rhamnosus CRL1505 and the beginning of social probiotic programs in Argentina. International Journal of Biotechnology for Wellness Industries 1: 189-198.
'Probiotics for everyone! The novel immunobiotic Lactobacillus rhamnosus CRL1505 and the beginning of social probiotic programs in Argentina ' () 1 International Journal of Biotechnology for Wellness Industries : 189 -198.
Villena, J., Vizoso-Pinto, M.G. and Kitazawa, H., 2016. Intestinal innate antiviral immunity and immunobiotics: beneficial effects against rotavirus infection. Frontiers in Immunology – Microbial Immunology 7: 563. https://doi.org/10.3389/fimmu.2016.00563
Wang, T., Town, T., Alexopoulou, L., Anderson, J.F., Fikrig, E. and Flavell, R.A., 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nature Medicine 10: 1366-1367. https://doi.org/10.1038/nm1140
Weiss, G., Rasmussen, S., Zeuthen, L.H., Nielsen, B.N., Jarmer, H., Jespersen, L. and Frokiaer, H., 2010. Lactobacillus acidophilus induces virus immune defense genes in murine dendritic cells by a toll-like receptor-2-dependent mechanism. Immunology 131: 268. https://doi.org/10.1111/j.1365-2567.2010.03301.x
Zelaya, H., Alvarez, S., Kitazawa, H. and Villena, J., 2016. Respiratory antiviral immunity and immunobiotics: beneficial effects on inflammation-coagulation interaction during influenza virus infection. Frontiers in Immunology – Microbial Immunology 7: 633. https://doi.org/10.3389/fimmu.2016.00633
Zhou, R., Wei, H., Sun, R. and Tian, Z., 2007a. Recognition of double-stranded RNA by TLR3 induces severe small intestinal injury in mice. Journal in Immunology 178: 4548-4556. https://doi.org/10.4049/jimmunol.178.7.4548
Zhou, R., Wei, H., Sun, R., Zhang, J. and Tian, Z., 2007b. NKG2D recognition mediates toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice. Proceedings of the National Academy of Sciences of the USA 104: 7512-7515. https://doi.org/10.1073/pnas.0700822104
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 416 | 148 | 21 |
| Gesamttextansichten | 23 | 2 | 0 |
| PDF-Downloads | 8 | 0 | 0 |
Proteolytic starter cultures with intrinsic immunomodulatory activities are desirably features for the development of functional foods, which would significantly reduce the cost of their production (one-strain starter) having an additional beneficial effect on the host. In this work, Lactobacillus delbrueckii strains were selected according to their ability to efficiently hydrolyse β-casein and to modulate the immune system. Among 36 strains evaluated, the highest proteolytic activities were found for L. delbrueckii subsp. lactis CRL581 and L. delbrueckii subsp. bulgaricus CRL656. The immunomodulatory effect of both strains and their β-casein hydrolysates (CRL581 and CRL656 hydrolysates, respectively) were studied in a murine model. Balb/c mice were fed lactobacilli or their hydrolysates for three days. One day after the last lactobacilli or hydrolysate treatments, mice were challenged with the Toll-like receptor 3 (TLR3) agonist poly(I:C) by intraperitoneal injection. Before and after poly(I:C) challenge the phagocytic and microbicidal activity of peritoneal macrophages, intestinal immunoglobulin A (IgA), cytokine profile, and histological analysis of the intestine were analysed. L. delbrueckii subsp. lactis CRL581 significantly increased the activation of peritoneal macrophages as well as the levels of intestinal IgA, interleukin (IL)-10 and interferon (IFN)-γ when compared to untreated controls. In addition, the CRL581 strain was able to significantly reduce the intestinal inflammatory damage triggered by TLR3 activation. L. delbrueckii CRL581 increased the levels of IL-10, IFN-γ and IFN-β, and reduced tumour necrosis factor alpha and IL-6 concentrations in the intestine of poly(I:C)-challenged mice. No immunomodulatory effects were observed for the CRL656 strain or for the CRL581 or CRL656 hydrolysates. The results of this work show that the technologically relevant and high proteolytic strain L. delbrueckii CRL581 is able to beneficially modulate the intestinal innate antiviral immune response. Although further studies with the CRL581 strain are required to corroborate and deepen its immunological effects, this bacterium is an interesting alternative for the development of new functional foods with antiviral capabilities.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 416 | 148 | 21 |
| Gesamttextansichten | 23 | 2 | 0 |
| PDF-Downloads | 8 | 0 | 0 |